Premature Aging, Vascular Disease and Endothelial Mechanotransduction
Premature Aging, Vascular Disease and Endothelial Mechanotransduction
批准号:
8072079
负责人:
William James Adams
金额:
$4.06万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-01 至 2013-04-30
关键词:
AdultAffectAgingAlopeciaAppearanceArteriesAtherosclerosisBiological ModelsBiomechanicsBlood VesselsCell DeathCell LineCell modelCellsCritical PathwaysDNA DamageDefectDevelopmentDiseaseEndothelial CellsEndotheliumEnsureEventFamilial HypercholesterolemiaFibroblastsFrequenciesFunctional disorderGenetic ProgrammingGoalsHarvestHeartHumanImpairmentInvestigationLaboratoriesLightLocationMeasuresModelingMolecularMutationMyocardial InfarctionOsteoporosisPathogenesisPatientsPhenotypePremature aging syndromeProgeriaResearchResistanceRiskRisk FactorsSignal PathwaySkin WrinklingStimulusStrokeSyndromeTestingTreesVascular DiseasesVascular EndotheliumWerner SyndromeWorkage relatedapolipoprotein B-100atherogenesisatheroprotectivebasebody systemearly onsetfluid flowinduced pluripotent stem cellinsightnormal agingpluripotencypremature atherosclerosisresponseshear stressstem
中文摘要
描述(由申请人提供):早衰综合征是几种已知的罕见突变导致多器官系统功能障碍的结果,其特征为骨质疏松、脱发和皮肤起皱等正常衰老特征。例如,患有哈钦森-吉尔福德早衰综合征(HGPS)和维尔纳综合征(WS)的患者会受到加速的、过早的动脉粥样硬化的影响,从而导致心脏病发作和中风。正如单基因疾病如家族性高胆固醇血症和家族性apoB-100缺陷已经为动脉粥样硬化的发病机制提供了强有力的分子见解一样,早衰综合征可能为揭示动脉粥样硬化发生的新关键途径提供了机会。虽然一些研究已经开始探索与这些综合征相关的血管缺陷,但血管内皮在与HGPS和WS相关的血管疾病发病机制中的作用仍未被探索。我们的实验室和其他人已经表明,内皮功能障碍是血管疾病发展的早期关键事件,它构成了心脏和血管内膜重要功能的多方面损害。我们已经证明,这种功能障碍可能是由生物力学刺激的存在或不存在引起的。生物力学力在内皮功能中起着重要作用,特别是在特定生物力学刺激下引起动脉粥样硬化抵抗或动脉粥样硬化易感表型时。这些不同的细胞表型是由特定的机械敏感信号通路激活的遗传程序的结果,以响应人类动脉树中存在的动脉粥样硬化保护或动脉粥样硬化倾向剪切应力。基于这些观察,生物力学力可以被认为是动脉粥样硬化的“局部危险因素”。在这里,我的工作假设是,动脉粥样硬化在早衰综合征中的早期出现是内皮细胞对动脉粥样硬化保护性剪切应力反应功能失调的结果。为了验证这一假设,在特异性目标1中,我们将首先从正常、HGPS和WS人类患者身上采集的成纤维细胞中创造诱导多能干细胞(iPS)。在特异性目标2中,我们将把这些iPS细胞分化成内皮细胞。我们将严格表征这种内皮细胞的结构和功能,以确保它具有成熟的动脉身份。确定了这一点,在特异性目标3中,我们将使正常和早衰模型iPS细胞衍生的内皮受到成人血管中存在的剪切应力波形的影响,并评估由此产生的内皮表型。这将表明过早衰老模型内皮是否由于机械转导功能失调而易患动脉粥样硬化。
英文摘要
DESCRIPTION (provided by applicant): Premature aging syndromes are the result of several identified rare mutations leading to the dysfunction of multiple organ systems characterized by features of normal aging such as osteoporosis, alopecia and skin wrinkling. Patients with Hutchinson-Gilford Progeria Syndrome (HGPS) and Werner's Syndrome (WS) for example, are affected by accelerated, premature atherosclerosis leading to heart attacks and strokes. Just as monogenic diseases such as familial hypercholesterolemia and familial defective apoB-100 have provided powerful molecular insights into the pathogenesis of atherosclerosis, premature aging syndromes may offer an opportunity to expose new critical pathways involved in atherogenesis. While several lines of investigation have begun to probe the vascular defects associated with these syndromes, the involvement of vascular endothelium in the pathogenesis of the vascular disease associated with HGPS and WS remains unexplored. Our laboratory and others have shown that endothelial dysfunction, which constitutes a multi- faceted impairment of the vital functions of the lining of the heart and blood vessels, is an early critical event in the development of vascular disease. We have shown that this dysfunction can be caused by the presence or absence of biomechanical stimuli. Biomechanical forces are important players in endothelial function, particularly in evoking atherosclerosis-resistant or atherosclerosis-susceptible phenotypes depending on the specific biomechanical stimulus. These distinct cellular phenotypes are the result genetic programs activated by specific mechanosensitive signaling pathways in response to atheroprotective or atheroprone shear stress present in the human arterial tree. Based on these observations, biomechanical forces can be considered "local risk factors" in atherogenesis. Here, it is my working hypothesis that the early appearance of atherosclerosis in premature aging syndromes is a consequence of dysfunctional endothelial cell responsiveness to atheroprotective shear stress. To test this hypothesis, in Specific Aim 1, we will first create induced pluripotent stem (iPS) cells from fibroblasts that have been harvested from normal, HGPS and WS human patients. In Specific Aim 2, we will differentiate these iPS cells into endothelium. We will rigorously characterize this endothelium both structurally and functionally to ensure it has a mature, arterial identity. Assured of this, in Specific Aim 3, we will subject the normal and premature aging model iPS cell-derived endothelium to shear stress waveforms present in the adult human vasculature and assess the resulting endothelial phenotype. This will indicate whether the premature aging model endothelium is predisposed atherosclerosis due to dysfunctional mechanotransduction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pharmacological induction of KLF2 and reversal of endothelial dysfunction for the treatment of hypertension
-
批准号:10484143
-
项目类别:
-
资助金额:$31.07万
-
财政年份:2022
-
负责人:William James Adams
-
依托单位:
Pharmacological induction of KLF2 and reversal of endothelial dysfunction for the treatment of hypertension
-
批准号:10688683
-
项目类别:
-
资助金额:$0.65万
-
财政年份:2022
-
负责人:William James Adams
-
依托单位:
Therapeutic Reversal of Endothelial Dysfunction in Atherogenesis
-
批准号:9335712
-
项目类别:
-
资助金额:$122.99万
-
财政年份:2013
-
负责人:William James Adams
-
依托单位:
Pharmacological Targeting of Endothelial Dysfunction in Atherogenesis
-
批准号:8523086
-
项目类别:
-
资助金额:$24.51万
-
财政年份:2013
-
负责人:William James Adams
-
依托单位:
Pharmacological Targeting of Endothelial Dysfunction in Atherogenesis
-
批准号:8918093
-
项目类别:
-
资助金额:$0.34万
-
财政年份:2013
-
负责人:William James Adams
-
依托单位:
Pharmacological Targeting of Endothelial Dysfunction in Atherogenesis
-
批准号:8719164
-
项目类别:
-
资助金额:$29.29万
-
财政年份:2013
-
负责人:William James Adams
-
依托单位:
Therapeutic Reversal of Endothelial Dysfunction in Atherogenesis
-
批准号:9141224
-
项目类别:
-
资助金额:$85.73万
-
财政年份:2013
-
负责人:William James Adams
-
依托单位:
Premature Aging, Vascular Disease and Endothelial Mechanotransduction
-
批准号:7910947
-
项目类别:
-
资助金额:$4.12万
-
财政年份:2010
-
负责人:William James Adams
-
依托单位:
Premature Aging, Vascular Disease and Endothelial Mechanotransduction
-
批准号:8242713
-
项目类别:
-
资助金额:$4.15万
-
财政年份:2010
-
负责人:William James Adams
-
依托单位:
海外基金